| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2144006 | Lung Cancer | 2007 | 8 Pages |
Abstract
In this large cohort, 67.7% of patients treated with first-line chemotherapy experienced a response or stable disease. Survival time and toxicity from this EAP were promising for this difficult-to-treat disease.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Coleman K. Obasaju, Zhishen Ye, Antoinette J. Wozniak, Chandra P. Belani, Mary-Louise Keohan, Helen J. Ross, Jonathan A. Polikoff, David M. Mintzer, Matthew J. Monberg, Pasi A. Jänne,